Renal Cancer - Results from #1240

The significance of CD14 in clear cell renal cell carcinoma progression and survival prognosis. November 3, 2022

Imaging of pediatric renal tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper focused on Wilms tumor and nephrogenic rests. November 2, 2022

Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy. November 2, 2022

Patient-Specific Mathematical Model of the Clear Cell Renal Cell Carcinoma Microenvironment. November 1, 2022

Diagnostic Performance of Contrast-Enhanced Ultrasound in the Evaluation of Small Renal Masses: A Systematic Review and Meta-Analysis. November 1, 2022

Treatment of Refractory Metastatic Renal Cell Carcinoma. November 1, 2022

Phase I/II study of multipeptide cancer vaccine IMA901 after single-dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long-term follow up. October 31, 2022

An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma. October 31, 2022

Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer. October 28, 2022

Perioperative outcomes of open and robot-assisted partial nephrectomy in patients with moderate to high complexity renal tumors. October 28, 2022

The Critical Gene Screening to Prevent Chromophobe Cell Renal Carcinoma Metastasis through TCGA and WGCNA. October 27, 2022

Nephrometry and cumulative morbidity after partial nephrectomy: A standardized assessment of complications in the context of PADUA and R.E.N.A.L. scores. October 27, 2022

PBRM1, SETD2 and BAP1 - the trinity of 3p in clear cell renal cell carcinoma. October 26, 2022

A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. October 25, 2022

Epigenetics in advanced renal cell carcinoma: potential new targets. October 25, 2022

Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma. October 24, 2022

Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms. October 24, 2022

A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma. October 21, 2022

Adjuvant therapy for renal cell carcinoma, finally a new standard? October 21, 2022

Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database. October 20, 2022

Page 63 of 456